Crossmark

Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT)

Crossref DOI link: https://doi.org/10.1007/s00380-022-02029-8

Published Online: 2022-01-28

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Graham, Carol Anne

Tan, Mary K.

Chew, Derek P.

Gale, Christopher P.

Fox, Keith A. A.

Bagai, Akshay

Henderson, Mark A.

Quraishi, Ata ur Rehman

Déry, Jean-Pierre

Cheema, Asim N.

Fisher, Harold

Brieger, David

Lutchmedial, Sohrab R.

Lavi, Shahar

Wong, Brian Y. L.

Cieza, Tomas

Mehta, Shamir R.

Brass, Neil

Goodman, Shaun G.

Yan, Andrew T. https://orcid.org/0000-0002-2063-7485
Funding

Funding for this research was provided by:

eli lilly

daiichi-sankyo
License Information

Text and Data Mining valid from 2022-01-28

Version of Record valid from 2022-01-28
More Information

Article History

Received: 18 July 2021

Accepted: 14 January 2022

First Online: 28 January 2022

Document is current

Any future updates will be listed below